EZH2 and diffuse large B-cell lymphoma: This synergy on transcriptome remodeling was also evident in another EZH2 mutant DLBCL line SuDHL10, where VTP50469 had minimal impact as single treatment yet together with EPZ-6438 caused differential expression of >600 genes (Fig. 6b, Supplementary Fig. 9b).